This study concludes that the NEAT1/miR-125b-5p/SLC1A5 cascade modulates diverse activities in oncogenicity, treatment efficacy, and immune cell profiles in head and neck/oral carcinoma. The gene discussed is SLC1A5; the disease is lip and oral cavity carcinoma.